Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis

Launched by UNIVERSITY HOSPITAL, TOURS · Sep 29, 2022

Keywords

ClinConnect Summary

This clinical trial, titled "Search for BIO Diagnostic and Prognostic Markers in Adult Vasculitis," is focused on finding new blood tests that can help doctors diagnose vasculitis more easily and predict how the disease may progress in patients. Currently, diagnosing vasculitis often involves painful procedures like tissue biopsies, which can come with risks. This study aims to discover reliable blood markers that can be used instead, making diagnosis and treatment planning safer and more straightforward for patients.

To participate in this study, individuals must be over 16 years old and currently experiencing active vasculitis, whether it's a new diagnosis or a relapse of a previous condition. Certain types of vasculitis, like IgA vasculitis and ANCA vasculitis, are eligible for the trial. Participants will have the opportunity to contribute to important research that could improve future care for people with this condition. It's important to note that those who are pregnant, have certain infections, or have received specific treatments recently may not qualify for this study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \> 16 years
• • Active vasculitis, new diagnosis or relapse
• • IgA vasculitis
• • ANCA vasculitis
• • Giant cell arteritis
• Exclusion Criteria:
• • Person who has objected to the processing of data
• • Pregnant woman
• • Patient positive for HIV, HBV, HCV
• • Treatment in the previous month with corticosteroids, immunosuppressive drugs or biotherapy.
• • Patient unable to understand the information leaflet
• • Adult under guardianship or curatorship